The JAK2 gene as a protagonist in chronic myeloproliferative neoplasms
AUTOR(ES)
Freitas, Renata Mendes de, Santos, Marcelo de Oliveira, Maranduba, Carlos Magno da Costa
FONTE
Rev. Bras. Hematol. Hemoter.
DATA DE PUBLICAÇÃO
2013
RESUMO
Documentos Relacionados
- Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms
- Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population
- The JAK2 V617F mutation in Philadelphia‐negative chronic myeloproliferative disorders
- Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F
- Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview